Replies to post #1002 on Enanta Pharmaceuticals Inc (ENTA)

[guyschmid]

Leerink revision is $42 to $41. Tweak as Q2 ENTA royalties lower. Expectations for FY 2015 slightly lower. In context, no big thing, but i would agree with Leerink - the co. needs to get the pipeline producing candidates.